跳至主要内容
临床试验/ACTRN12618001762246
ACTRN12618001762246尚未招募不适用

A pilot series of n-of-1 randomised controlled trials to compare pregabalin and gabapentin in persistent neuropathic pain.

Department of Rehabilitation Medicine Port Kembla Hospital0 个研究点目标入组 40 人开始时间: 2018年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Existing patient at Port Kembla Hospital
  • 2. Age 18 years or greater
  • 3. Existing diagnosis of chronic and stable neuropathic pain.
  • 4. Currently prescribed gabapentin for neuropathic pain.
  • 5. Willingness to maintain pain medications and treatments throughout the trial.
  • 6. Capable English speaker
  • 7. Able to be reliably contacted by telephone.

排除标准

  • 1. Currently breastfeeding or pregnant
  • 2. Gabapentin or pregabalin allergy or intolerance
  • 3. Active or past history of seizures
  • 4. Creatinine clearance under 30 mL/min.
  • 5. Likelihood of surgery during the trial
  • 6. Inability to attend review visits

研究者

发起方
Department of Rehabilitation Medicine Port Kembla Hospital

相似试验